JAGX · catalysts, narrative & risks

Company Snapshot (as of 2026-10-02/03)

Jaguar Health, Inc. (NASDAQ: JAGX) is a commercial-stage pharmaceuticals company that develops plant-derived (crofelemer-based) prescription and non-prescription medicines for gastrointestinal conditions in people and animals, operating through Animal Health and Human Health segments [21], [22]. It was founded by Lisa A. Conte and is headquartered in San Francisco, CA [22]. As of the Oct 2 close, the stock traded at ~$3.66 (down 7.34%) with a market cap of ~$1.90M, and the 52-week range stretched from $2.35 to ~$1,268 [20], [21].